{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:13:47Z","timestamp":1795058027184,"version":"4.10.2"},"reference-count":51,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>miR profile could be associated to CV risk, and also to prognosis\/outcome in response to therapeutic approach. We aimed to evaluate if anti-hypertensive drugs enalapril, losartan or olmesartan have effects on monocyte miR profile in essential hypertensives without target organ involvement. For this purpose, 82 hypertensives and 49 controls were included; we evaluated SBP\/DBP, lipid profile, glucose, CRP, fibrinogen, arterial stiffness indices (PWV; AIx), and cIMT at baseline (T0) and after 24 weeks of treatment (T1). Subjects with LDL-C \u2265 160 mg\/dL, TG \u2265 200 mg\/dL, BMI \u2265 30, and other additional CV risk factors were excluded. Patients who were prescribed to receive once-a-day enalapril 20 mg, losartan 100 mg or olmesartan 20 mg were eligible for the study. At T1, we found a significant improvement of SBP (\u221218.5%), DBP (\u221218%), HDL-C and LDL-C (+3% and \u22125.42%), glucose (\u22122.15%), BMI (\u22123.23%), fibrinogen (\u221211%), CRP (\u221217.5%,), AIx (\u221249.1%) PWV (\u221232.2%), and monocyte miR expression (miR-221: \u221228.4%; miR-222: \u221236%; miR-145: +41.7%) with respect to baseline. miR profile was compared to control subjects at baseline and at T1. We found some little difference in the behaviour of the three treatments on some variables: olmesartan was the most effective in reducing fibrinogen, DBP, CRP, and AIx (\u221213.1%, \u221219.3%, \u221221.4%, and \u221256.8%, respectively). Enalapril was the drug more significantly increasing the expression of miR-145. In conclusion, enalapril, losartan and olmesartan are effective in improving mechanical and humoral factors associated to AS and atherogenesis. These drugs appear to be able to modify miRs 221\/222 and miR-145 expression in drug-na\u00efve hypertensives, making it closer to that of control subjects; additionally, this provides a good blood pressure compensation, contributing to slow the progression of vascular damage.<\/jats:p>","DOI":"10.3390\/biomedicines9080860","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T22:06:48Z","timestamp":1626991608000},"page":"860","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0272-2237","authenticated-orcid":false,"given":"Giuseppe","family":"Mandraffino","sequence":"first","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"},{"name":"Lipid Center, Internal Medicine Unit, University of Messina, 98122 Messina, Italy"},{"name":"Laboratory of Clinical Biochemistry, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4383-0314","authenticated-orcid":false,"given":"Alberto","family":"Lo Gullo","sequence":"additional","affiliation":[{"name":"IRCCS Neurolesi Bonino Pulejo, 98123 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cinquegrani","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"D\u2019Ascola","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Sinicropi","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-5467","authenticated-orcid":false,"given":"Egidio","family":"Imbalzano","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Blando","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Maurizio","family":"Campo","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Morace","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Giuffrida","sequence":"additional","affiliation":[{"name":"IRCCS Neurolesi Bonino Pulejo, 98123 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-8917","authenticated-orcid":false,"given":"Salvatore","family":"Campo","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Department of Biomedical and Dental Sciences and Morphofunctional Images, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Squadrito","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Scuruchi","sequence":"additional","affiliation":[{"name":"Lipid Center, Internal Medicine Unit, University of Messina, 98122 Messina, Italy"},{"name":"Laboratory of Clinical Biochemistry, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nature05874","article-title":"Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project","volume":"447","author":"Birney","year":"2007","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/physrev.00006.2010","article-title":"MicroRNAs in development and disease","volume":"91","author":"Sayed","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/ATVBAHA.112.300144","article-title":"MicroRNAs in metabolic disease","volume":"33","author":"Ramirez","year":"2013","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/bjh.12828","article-title":"MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma","volume":"165","author":"Campo","year":"2014","journal-title":"Br. J. Haematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI62876","article-title":"MicroRNAs in cardiovascular disease: From pathogenesis to prevention and treatment","volume":"123","author":"Quiat","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2362.2009.02110.x","article-title":"Effect of atorvastatin on microRNA 221\/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease","volume":"39","author":"Minami","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/jhh.2014.7","article-title":"Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement","volume":"28","author":"Mandraffino","year":"2014","journal-title":"J. Hum. Hypertens"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mandraffino, G., Aragona, C.O., Cairo, V., Scuruchi, M., Lo Gullo, A., D\u2019Ascola, A., Alibrandi, A., Loddo, S., Quartuccio, S., and Morace, C. (2017). Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173030"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41440-019-0343-2","article-title":"Exosomal microRNAs as a promising theragnostic tool for essential hypertension","volume":"43","author":"Jayaseelan","year":"2020","journal-title":"Hypertens Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"H1486","DOI":"10.1152\/ajpheart.00888.2020","article-title":"Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers","volume":"320","author":"Tan","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jcp.29064","article-title":"MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients","volume":"235","author":"Sardu","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sardu, C., Modugno, P., Castellano, G., Scisciola, L., Barbieri, M., Petrella, L., Fanelli, M., Macchia, G., Caradonna, E., and Massetti, M. (2021). Atherosclerotic Plaque Fissuration and Clinical Outcomes in Pre-Diabetics vs. Normoglycemics Patients Affected by Asymptomatic Significant Carotid Artery Stenosis at 2 Years of Follow-Up: Role of microRNAs Modulation: The ATIMIR Study. Biomedicines, 9.","DOI":"10.20944\/preprints202102.0577.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood-2006-01-012369","article-title":"MicroRNAs modulate the angiogenic properties of HUVECs","volume":"108","author":"Poliseno","year":"2006","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1074\/jbc.M808788200","article-title":"Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype","volume":"284","author":"Davis","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tips.2007.10.014","article-title":"Targeting microRNA expression to regulate angiogenesis","volume":"29","author":"Kuehbacher","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12265-010-9163-0","article-title":"Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury","volume":"3","author":"Song","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exger.2011.10.004","article-title":"MicroRNA changes in human arterial endothelial cells with senescence: Relation to apoptosis, eNOS and inflammation","volume":"47","author":"Rippe","year":"2012","journal-title":"Exp. Gerontol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1074\/jbc.M111.321646","article-title":"Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221","volume":"287","author":"Santhekadur","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.atherosclerosis.2010.12.024","article-title":"Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration","volume":"215","author":"Zhu","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","article-title":"MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis","volume":"61","author":"Ogawa","year":"2012","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cbf.3005","article-title":"miRNA-221 and miRNA-222 synergistically function to promote vascular calcification","volume":"32","author":"Mackenzie","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/jcb.24075","article-title":"MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression","volume":"113","author":"Wang","year":"2012","journal-title":"J. Cell Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15672","DOI":"10.1074\/jbc.M111.322669","article-title":"Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells","volume":"287","author":"Jin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2009.02.013","article-title":"MicroRNA-221 regulates high glucose-induced endothelial dysfunction","volume":"381","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/cdd.2009.153","article-title":"The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease","volume":"16","author":"Elia","year":"2009","journal-title":"Cell Death Differ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19199","DOI":"10.1074\/jbc.M112.341073","article-title":"MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels","volume":"287","author":"Turczynska","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2011.09.004","article-title":"The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells","volume":"219","author":"Yamaguchi","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.200912096","article-title":"MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro","volume":"189","author":"Quintavalle","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/CIRCRESAHA.116.305178","article-title":"TGFbeta Triggers miR-143\/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization","volume":"116","author":"Climent","year":"2015","journal-title":"Circ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4161\/cc.8.21.9837","article-title":"MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease","volume":"8","author":"Zhang","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1440-1681.2010.05407.x","article-title":"Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients","volume":"37","author":"Sardo","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00005650-200106000-00008","article-title":"Medical care expenditures for hypertension, its complications, and its comorbidities","volume":"39","author":"Hodgson","year":"2001","journal-title":"Med. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11739-011-0548-0","article-title":"Structural abnormalities of small resistance arteries in essential hypertension","volume":"7","author":"Rizzoni","year":"2012","journal-title":"Intern. Emerg. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/revneuro-2015-0041","article-title":"Angiotensin II-triggered kinase signaling cascade in the central nervous system","volume":"27","author":"Bali","year":"2016","journal-title":"Rev. Neurosci."},{"key":"ref_38","first-page":"2114","article-title":"Identification of microRNAs present in congenital heart disease associated copy number variants","volume":"17","author":"Xing","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/BIR-140657","article-title":"Shear sensitive microRNAs and atherosclerosis","volume":"51","author":"Alexy","year":"2014","journal-title":"Biorheology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.RES.0000043501.47934.FA","article-title":"Superoxide mediates the actions of angiotensin II in the central nervous system","volume":"91","author":"Zimmerman","year":"2002","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.116.025950","article-title":"Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction","volume":"135","author":"Messerli","year":"2017","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"354517","DOI":"10.1155\/2015\/354517","article-title":"Human miR-221\/222 in Physiological and Atherosclerotic Vascular Remodeling","volume":"2015","author":"Chistiakov","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.RES.0000265065.26744.17","article-title":"Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells","volume":"100","author":"Suarez","year":"2007","journal-title":"Circ. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fmed.2019.00280","article-title":"Hypertension Associated with Hyperlipidemia Induced Different MicroRNA Expression Profiles in Plasma, Platelets, and Platelet-Derived Microvesicles; Effects of Endothelial Progenitor Cell Therapy","volume":"6","author":"Alexandru","year":"2019","journal-title":"Front. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/CIRCULATIONAHA.110.012237","article-title":"Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection","volume":"124","author":"Li","year":"2011","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2011.11.008","article-title":"Cell-specific effects of miR-221\/222 in vessels: Molecular mechanism and therapeutic application","volume":"52","author":"Liu","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vph.2018.11.006","article-title":"The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease","volume":"112","author":"Vacante","year":"2019","journal-title":"Vascul. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","article-title":"MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation","volume":"105","author":"Cheng","year":"2009","journal-title":"Circ. Res."},{"key":"ref_49","first-page":"506","article-title":"miR-145 is critical for modulation of vascular smooth muscle cell proliferation in human carotid artery stenosis","volume":"32","author":"Han","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40001-020-00403-8","article-title":"MicroRNA-145 is involved in endothelial cell dysfunction and acts as a promising biomarker of acute coronary syndrome","volume":"25","author":"Wu","year":"2020","journal-title":"Eur. J. Med. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Churov, A., Summerhill, V., Grechko, A., Orekhova, V., and Orekhov, A. (2019). MicroRNAs as Potential Biomarkers in Atherosclerosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225547"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/860\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:33:22Z","timestamp":1760164402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biomedicines9080860"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9080860","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}